Informed Consent to Microsatellite Instability and Immunohistochemistry Screening for Lynch Syndrome

Abstract

Routine microsatellite instability and immunohistochemistry screening of colorectal cancers can assist in identifying a significant proportion of cancers attributable to Lynch syndrome. This article considers whether it is necessary to obtain patient informed consent for microsatellite instability and immunohistochemistry screening.